SEC Company Response from Ocugen, Inc. (OCGN) (CIK 0001372299) (OCGN) — May 4, 2020
Ocugen, Inc. (OCGN) (CIK 0001372299)
Date: May 4, 2020 · CIK: 0001372299 · Accession: 0001104659-20-056162
AI Filing Summary & Sentiment
File numbers found in text: 333-237456
Letter
Re:
Ocugen, Inc. 5 Great Valley Parkway, Suite 160
Malvern, Pennsylvania 19355
May 4, 2020
VIA EDGAR
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Ocugen, Inc.
Registration Statement on Form S-3
Filed March 27, 2020 (File No. 333-237456)
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Ocugen, Inc. (the “Company”) hereby requests that the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-237456) (the “Registration Statement”) be accelerated so that the Company’s Registration Statement will become effective at 4:01 PM, eastern time, on May 5, 2020, or as soon as thereafter as is practicable.
Please contact Thomas Mitchell of Pepper Hamilton LLP, counsel to the Company, at (949) 567-3543 to provide notice of effectiveness, or if you have any questions or comments concerning this request.
[Remainder of the page intentionally left blank]
Very truly yours,
OCUGEN, INC.
Show Raw Text
CORRESP 1 filename1.htm Ocugen, Inc. 5 Great Valley Parkway, Suite 160 Malvern, Pennsylvania 19355 May 4, 2020 VIA EDGAR U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Ocugen, Inc. Registration Statement on Form S-3 Filed March 27, 2020 (File No. 333-237456) Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Ocugen, Inc. (the “Company”) hereby requests that the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-237456) (the “Registration Statement”) be accelerated so that the Company’s Registration Statement will become effective at 4:01 PM, eastern time, on May 5, 2020, or as soon as thereafter as is practicable. Please contact Thomas Mitchell of Pepper Hamilton LLP, counsel to the Company, at (949) 567-3543 to provide notice of effectiveness, or if you have any questions or comments concerning this request. [Remainder of the page intentionally left blank] Very truly yours, OCUGEN, INC. By: /s/ Shankar Musunuri Name: Shankar Musunuri, Ph.D., MBA Title: Chief Executive Officer & Chairman Ocugen, Inc. — Acceleration Letter